$TONGRENTANGCARE(02667.HK) won't go the same way as Jiangxi Bio and head for a 50% drop, will it?
Jiangxi Institute of Biological Products Inc. manufactures and exports biological products including Tetanus Antitoxin and Veterinary Medicine. The company offe...
Jiangxi Bioproducts rebounded 1.1% to close at HK$6.37 after a volatile session, recovering from an intraday low of HK$6.02 triggered by a profit warning yesterday. The stock initially fell 26% following the warning but rallied on approval of an animal health product, which offset concerns about its Hong Kong listing sustainability. Despite the bounce, the stock trades 40.7% below its 52-week high of HK$10.75 and well below its 20-day moving average of HK$7.483, with a year-to-date decline of 34.9%, though its PE of 18.7x and PB of 3.56x are moderate for the sector.
Jiangxi Bio rises 8% on vet antitoxin approval
Jiangxi Bio Soars Over 5% on Vet Product Approval
Jiangxi Bio drops over 5% in Hong Kong trading
Jiangxi Bio drops 2% in Hong Kong trading
Jiangxi Bio Surges 13% on Trading Day Amid Governance Concerns
Jiangxi Bio falls 5% amid product and governance concerns
$TONGRENTANGCARE(02667.HK) won't go the same way as Jiangxi Bio and head for a 50% drop, will it?
$JIANGXI BIO(06915.HK)Scary😱, directly halved

JIANGXI BIO
HK06915
Hello, I'm Lu Xian. I research the investment field and share overseas information. The previous post shared about Jiangxi Bio, and today let's look at a leading consumer electronics company that is going for a Hong Kong listing from the A-share market—Luxshare Precision. The company has been listed on the A-share market for many years, with consumer electronics as its core business, while expanding into the automotive electronics and data center sectors. This issuance is of a large scale, with a focus on the A/H discount, cornerstone lock-up, and post-listing capital absorption...

